-
Je něco špatně v tomto záznamu ?
Regulation of Cell-Nanoparticle Interactions through Mechanobiology
M. Cassani, F. Niro, S. Fernandes, D. Pereira-Sousa, S. Faes Morazzo, H. Durikova, T. Wang, L. González-Cabaleiro, J. Vrbsky, J. Oliver-De La Cruz, S. Klimovic, J. Pribyl, T. Loja, P. Skladal, F. Caruso, G. Forte
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- adaptorové proteiny signální transdukční metabolismus MeSH
- buněčný převod mechanických signálů účinky léků MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nanočástice * chemie MeSH
- nanomedicína MeSH
- signální dráha Hippo MeSH
- signální proteiny YAP MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Bio-nano interactions have been extensively explored in nanomedicine to develop selective delivery strategies and reduce systemic toxicity. To enhance the delivery of nanocarriers to cancer cells and improve the therapeutic efficiency, different nanomaterials have been developed. However, the limited clinical translation of nanoparticle-based therapies, largely due to issues associated with poor targeting, requires a deeper understanding of the biological phenomena underlying cell-nanoparticle interactions. In this context, we investigate the molecular and cellular mechanobiology parameters that control such interactions. We demonstrate that the pharmacological inhibition or the genetic ablation of the key mechanosensitive component of the Hippo pathway, i.e., yes-associated protein, enhances nanoparticle internalization by 1.5-fold. Importantly, this phenomenon occurs independently of nanoparticle properties, such as size, or cell properties such as surface area and stiffness. Our study reveals that the internalization of nanoparticles in target cells can be controlled by modulating cell mechanosensing pathways, potentially enhancing nanotherapy specificity.
Department of Biochemistry Faculty of Science Masaryk University 62500 Brno Czech Republic
Department of Chemical Engineering The University of Melbourne Parkville Victoria 3010 Australia
Faculty of Medicine Department of Biomedical Sciences Masaryk University 62500 Brno Czech Republic
Institute for Bioengineering of Catalonia 08028 Barcelona Spain
International Clinical Research Center St Anne's University Hospital 65691 Brno Czech Republic
Molecular Medicine CEITEC Masaryk University 62500 Brno Czech Republic
Nanobiotechnology Core Facility CEITEC Masaryk University 62500 Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009852
- 003
- CZ-PrNML
- 005
- 20250429134919.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.nanolett.4c04290 $2 doi
- 035 __
- $a (PubMed)39772635
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cassani, Marco $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia $1 https://orcid.org/0000000184377734
- 245 10
- $a Regulation of Cell-Nanoparticle Interactions through Mechanobiology / $c M. Cassani, F. Niro, S. Fernandes, D. Pereira-Sousa, S. Faes Morazzo, H. Durikova, T. Wang, L. González-Cabaleiro, J. Vrbsky, J. Oliver-De La Cruz, S. Klimovic, J. Pribyl, T. Loja, P. Skladal, F. Caruso, G. Forte
- 520 9_
- $a Bio-nano interactions have been extensively explored in nanomedicine to develop selective delivery strategies and reduce systemic toxicity. To enhance the delivery of nanocarriers to cancer cells and improve the therapeutic efficiency, different nanomaterials have been developed. However, the limited clinical translation of nanoparticle-based therapies, largely due to issues associated with poor targeting, requires a deeper understanding of the biological phenomena underlying cell-nanoparticle interactions. In this context, we investigate the molecular and cellular mechanobiology parameters that control such interactions. We demonstrate that the pharmacological inhibition or the genetic ablation of the key mechanosensitive component of the Hippo pathway, i.e., yes-associated protein, enhances nanoparticle internalization by 1.5-fold. Importantly, this phenomenon occurs independently of nanoparticle properties, such as size, or cell properties such as surface area and stiffness. Our study reveals that the internalization of nanoparticles in target cells can be controlled by modulating cell mechanosensing pathways, potentially enhancing nanotherapy specificity.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a signální proteiny YAP $7 D000091102
- 650 _2
- $a buněčný převod mechanických signálů $x účinky léků $7 D040542
- 650 _2
- $a nanomedicína $7 D050997
- 650 _2
- $a adaptorové proteiny signální transdukční $x metabolismus $7 D048868
- 650 _2
- $a signální dráha Hippo $7 D000090683
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a zvířata $7 D000818
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Niro, Francesco $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London WC2R 2LS, U.K $u Faculty of Medicine, Department of Biomedical Sciences, Masaryk University, 62500 Brno, Czech Republic
- 700 1_
- $a Fernandes, Soraia $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia
- 700 1_
- $a Pereira-Sousa, Daniel $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u Faculty of Medicine, Department of Biomedical Sciences, Masaryk University, 62500 Brno, Czech Republic
- 700 1_
- $a Faes Morazzo, Sofia $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u Faculty of Medicine, Department of Biomedical Sciences, Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/0000000168645209
- 700 1_
- $a Durikova, Helena $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia $1 https://orcid.org/0000000166139177
- 700 1_
- $a Wang, Tianzheng $u Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia
- 700 1_
- $a González-Cabaleiro, Lara $u Departamento de Química Física, Universidade de Vigo, Campus Universitario As Lagoas Marcosende, Vigo 36310, Spain
- 700 1_
- $a Vrbsky, Jan $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic
- 700 1_
- $a Oliver-De La Cruz, Jorge $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain
- 700 1_
- $a Klimovic, Simon $u Nanobiotechnology Core Facility, CEITEC Masaryk University, 62500 Brno, Czech Republic $u Department of Biochemistry, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic
- 700 1_
- $a Pribyl, Jan $u Nanobiotechnology Core Facility, CEITEC Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/0000000312323694 $7 mub2012735441
- 700 1_
- $a Loja, Tomas $u Molecular Medicine, CEITEC Masaryk University, 62500 Brno, Czech Republic
- 700 1_
- $a Skladal, Petr $u Department of Biochemistry, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic
- 700 1_
- $a Caruso, Frank $u Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia $1 https://orcid.org/000000020197497X $7 jo2012715762
- 700 1_
- $a Forte, Giancarlo $u International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic $u School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London WC2R 2LS, U.K
- 773 0_
- $w MED00006609 $t Nano letters $x 1530-6992 $g Roč. 25, č. 7 (2025), s. 2600-2609
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39772635 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134915 $b ABA008
- 999 __
- $a ok $b bmc $g 2311317 $s 1246933
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 25 $c 7 $d 2600-2609 $e 20250108 $i 1530-6992 $m Nano letters $n Nano Lett $x MED00006609
- LZP __
- $a Pubmed-20250415